U.S. stock night market opening fluctuations: AngloGold Ashanti fell 7.44% in the night market; Atlantic rose 7.36% in the night market
I'm LongbridgeAI, I can summarize articles.AngloGold Ashanti fell 7.44% in the night session; Atlantic rose 7.36% in the night session; Quhuo rose 21.96% in the night session; Moleculin Biotech rose 19.27% in the night session; Larimar Therapeutics rose 16.12% in the night session
U.S. Stock Night Market Opening Movements
AngloGold Ashanti fell 7.44% in the night market. Based on recent key news:
-
On June 27, FactSet's latest survey showed that the median target price estimate for AngloGold Ashanti by 13 analysts was downgraded from 121.17 to 115, a decrease of 5.1%. This news weakened market confidence in the stock, leading to a price drop.
-
On June 27, AngloGold Ashanti's stock price fell 5.1% over the past 5 days, while the S&P index dropped 1.91%. There was no significant performance in the stock price in the short term, further exacerbating market concerns.
-
On June 27, 11 out of 14 analysts gave AngloGold Ashanti a positive outlook, but 2 remained neutral and 1 was conservatively pessimistic. This divergence created uncertainty for investors regarding future trends, impacting the stock price. The recent volatility in the gold market requires investors to be cautious.
Atlantic rose 7.36% in the night market, with no significant news recently. Trading was active, and capital flow was evident. Considering sector and industry trends, the stock showed significant volatility, and specific reasons need further observation.
Top Gainers in the U.S. Night Market
Qutoutiao rose 21.96% in the night market. Based on recent key news:
-
On June 26, Qutoutiao's digital asset subsidiary HYPERLIQUID STRATEGIES INC recently launched multiple ecosystem expansion plans. COO Jeroen Nieuwkoop indirectly received over 420,000 restricted stock units by the end of June 2026 under an executive placement agreement. The company began trading options on the Nasdaq options market in March 2026 to enhance the liquidity of its stock. As the commercialization of space infrastructure and the standardization of digital assets progress, capital flows are increasingly targeting platform companies with established use cases and compliant market access. These factors drove the rise in Qutoutiao's stock price.
-
No other significant news recently.
-
No other significant news recently. Digital assets and platform companies are receiving capital attention.
Moleculin Biotech rose 19.27% in the night market, with no significant news recently. Trading was active, and capital flow was evident. Considering sector and industry trends, the stock showed significant volatility, and specific reasons need further observation.
Larimar Therapeutics rose 16.12% in the night market. Based on recent key news:
-
On June 27, Larimar Therapeutics announced it would hold a live investor webcast on June 29 to discuss regulatory updates and long-term open-label study data for the Friedreich’s ataxia treatment drug nomlabofusp. This news boosted market confidence and drove the stock price up
-
On June 26, Larimar Therapeutics announced that its management is optimistic about future development and stated that it will continue to advance the clinical development plan for nomlabofusp. Investors expressed optimism about the company's future prospects, leading to a rise in stock prices.
-
On June 26, Larimar Therapeutics detailed its financial status and future plans in a periodic report submitted to the SEC, further enhancing investor confidence and driving up stock prices. The biotechnology industry has performed strongly recently, with significant capital inflows